BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $255,945 | -3.4% | 250,000 | 0.0% | 0.00% | – |
| Q4 2022 | $265,052 | +6.9% | 250,000 | 0.0% | 0.00% | – |
| Q3 2022 | $248,000 | -92.7% | 250,000 | -92.8% | 0.00% | -100.0% |
| Q2 2022 | $3,414,000 | -1.4% | 3,450,000 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $3,462,000 | -4.8% | 3,450,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $3,638,000 | +2.3% | 3,450,000 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $3,555,000 | -0.9% | 3,450,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $3,588,000 | +1.5% | 3,450,000 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $3,535,000 | -4.3% | 3,450,000 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $3,695,000 | +2.6% | 3,450,000 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $3,602,000 | -15.0% | 3,450,000 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $4,237,000 | -48.8% | 3,450,000 | -56.6% | 0.01% | -57.1% |
| Q1 2020 | $8,277,000 | -23.4% | 7,950,000 | -22.1% | 0.03% | 0.0% |
| Q4 2019 | $10,805,000 | +19.2% | 10,200,000 | +10.9% | 0.03% | +3.7% |
| Q3 2019 | $9,063,000 | +16.4% | 9,200,000 | +22.7% | 0.03% | +12.5% |
| Q2 2019 | $7,786,000 | -5.2% | 7,500,000 | -6.2% | 0.02% | -11.1% |
| Q1 2019 | $8,215,000 | +44.1% | 8,000,000 | +39.1% | 0.03% | +22.7% |
| Q4 2018 | $5,700,000 | -2.3% | 5,750,000 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $5,833,000 | -47.6% | 5,750,000 | -51.5% | 0.02% | -48.8% |
| Q1 2018 | $11,134,000 | +24.4% | 11,850,000 | +31.7% | 0.04% | +26.5% |
| Q4 2017 | $8,948,000 | – | 9,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |